 The news we are about to share with you is about cancer. To write a new ending to this insidious disease, we need to create a new beginning. We are proud to announce that Memorial Sloan Kettering and Hackensack Meridian Health are creating an extraordinary strategic partnership to change the course of cancer. This is truly an unprecedented partnership, an exciting collision of the brightest minds and discoveries from Memorial Sloan Kettering and Hackensack Meridian Health. Both MSK as well as Hackensack Meridian have world-class experts. There are so many talented clinicians and researchers at each of our institutions and I think that sharing our ideas, our resources and our data can only serve to accelerate cancer discovery and innovation. Having this formal relationship has been helpful to combine patient initiatives and also just gives our patients access more broadly to the things both centers have to offer. I think one of the great opportunities for the collaboration with Hackensack is to deliver better patient care and to take research to the next level. When you combine the power of two large cancer centers that see different types of patients, different volumes of patients, you can get a much clearer picture of how cancer care is delivered and how we can learn from those sorts of real-world experiences. We realize over time what additional things we can do. We're able to set up a research grant collaboration in the area of immunoculogy and we were also able to do that in population health. And both of those have yielded multiple projects that came together in a collaborative way. And I think none of those would likely have happened individually without the partnership. Our role really for the shared care nurses is that we facilitate communication and make sure that if a physician in Hackensack or a provider in Hackensack needs to speak to somebody in MSK, they can in real time. We have nurses at MSK and at Hackensack University Medical Center that communicate multiple times a day if needed and speak to the patients, speak to each other and really make that care seamless and coordinated. Our collaborative efforts are exactly the same. We work really closely with the oncologists. It's very collaborative. They listen to our input and we obviously listen to what they have to say. We're two large institutions with similar values in terms of wanting to provide the best care for patients. I've had multiple patients tell me how appreciative they are of this partnership because it's really allowed them to have the comprehensive care that they need at a place that's convenient for them. I think we all are working in the same direction and we all have the same goals and this makes it much, much more exciting to develop collaborations together. I think the first five years has been very encouraging in terms of the potential of this partnership and what we can do. I think ultimately what we are most proud of with this and probably any collaboration is to the extent it helps us bring new treatments to patients in a faster way.